401 related articles for article (PubMed ID: 26149936)
1. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.
Lima FA; Miyaji EN; Quintilio W; Raw I; Ho PL; Oliveira ML
Vaccine; 2013 May; 31(20):2465-70. PubMed ID: 23541622
[TBL] [Abstract][Full Text] [Related]
3. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
[TBL] [Abstract][Full Text] [Related]
4. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA
Front Immunol; 2019; 10():1520. PubMed ID: 31333656
[TBL] [Abstract][Full Text] [Related]
5. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders.
Robinson C; Baehr C; Schmiel SE; Accetturo C; Mueller DL; Pravetoni M
Hum Vaccin Immunother; 2019; 15(4):909-917. PubMed ID: 30625019
[TBL] [Abstract][Full Text] [Related]
6. CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in mice.
DeJong MA; Wolf MA; Bitzer GJ; Hall JM; Sen-Kilic E; Blake JM; Petty JE; Wong TY; Barbier M; Campbell JD; Bevere JR; Damron FH
Vaccine; 2022 Aug; 40(35):5229-5240. PubMed ID: 35927132
[TBL] [Abstract][Full Text] [Related]
7. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I
Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709
[TBL] [Abstract][Full Text] [Related]
8. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S
Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019
[TBL] [Abstract][Full Text] [Related]
9. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
10. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination.
Prelog M; Almanzar G; Rieber N; Ottensmeier B; Zlamy M; Liese J
Vaccine; 2013 Jan; 31(2):387-93. PubMed ID: 23142306
[TBL] [Abstract][Full Text] [Related]
11. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
[TBL] [Abstract][Full Text] [Related]
12. Induction of Bordetella pertussis-specific immune memory by DTPa vaccines.
Morel S; Denoël P; Godfroid F; Cortvrindt C; Vanderheyde N; Poolman J
Vaccine; 2011 Apr; 29(18):3449-55. PubMed ID: 21382483
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
[TBL] [Abstract][Full Text] [Related]
14. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
Lavigne MV; Castro M; Andino J; Manghi M
Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women.
Huygen K; Caboré RN; Maertens K; Van Damme P; Leuridan E
Vaccine; 2015 Aug; 33(33):4117-23. PubMed ID: 26187257
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
[TBL] [Abstract][Full Text] [Related]
18. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
19. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.
van Gageldonk PG; van Schaijk FG; van der Klis FR; Berbers GA
J Immunol Methods; 2008 Jun; 335(1-2):79-89. PubMed ID: 18407287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
